Fredrick F. Van Goor,Rossitza Gueorguieva Alargova,Tim Edward Alcacio,Sneha G. Arekar,Steven C. Johnston,Irina Nicolaevna Kadiyala,Ali Keshavarz-Shokri,Mariusz Krawiec,Elaine Chungmin Lee,Ales Medek,P
申请号：
US15643182
公开号：
US20180153874A1
申请日:
2017.07.06
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to pharmaceutical compositions comprising a compound of Formula I in combination with one or both of a Compound of Formula II and/or a Compound of Formula III. The invention also relates to solid forms and to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis.
